# Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke

Study · id `cardio:ct-nct02898610` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02898610](<https://clinicaltrials.gov/study/NCT02898610>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02898610

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3154 participants.

## Technical summary

Registry record NCT02898610. Randomized; no masking; primary purpose prevention. Start 2016-12-12 (actual); primary completion 2024-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 3154 participants (enrolled count; ClinicalTrials.gov record NCT02898610, source copy `cardio:ctgov-nct02898610-2025-03-13`, retrieved 2026-10-31)
- Started: 2016-12-12 (actual) (ClinicalTrials.gov record NCT02898610, source copy `cardio:ctgov-nct02898610-2025-03-13`, retrieved 2026-10-31)
- Primary completion: 2024-01-31 (actual) (ClinicalTrials.gov record NCT02898610, source copy `cardio:ctgov-nct02898610-2025-03-13`, retrieved 2026-10-31)
- Completion: 2024-01-31 (actual) (ClinicalTrials.gov record NCT02898610, source copy `cardio:ctgov-nct02898610-2025-03-13`, retrieved 2026-10-31)
- Countries: Belgium; Canada; Czechia; Denmark; Estonia; Germany; Ireland; Lithuania; Netherlands; Poland; Portugal; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT02898610, source copy `cardio:ctgov-nct02898610-2025-03-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02898610-2025-03-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke
- Acronym: CONVINCE
- Condition: Ischemic Attack, Transient
- Condition: Stroke
- Intervention (Drug): Colchicine
- Lead sponsor: University College Dublin
- Lead sponsor class: OTHER
- Collaborator: Health Research Board, Ireland
- Collaborator class: OTHER
- Collaborator: Irish Heart Foundation
- Collaborator class: OTHER
- Collaborator: University of Limerick
- Collaborator class: OTHER
- Collaborator: University of Edinburgh
- Collaborator class: OTHER
- Collaborator: National University of Ireland, Galway, Ireland
- Collaborator class: OTHER
- Collaborator: Universitat de Lleida
- Collaborator class: OTHER
- Collaborator: Universitaire Ziekenhuizen KU Leuven
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: University College Dublin (`cardio:org-university-college-dublin`)
- Registry lists this organization as a collaborator: Health Research Board, Ireland (`cardio:org-health-research-board-ireland`)
- Registry lists this organization as a collaborator: University of Edinburgh (`cardio:org-university-of-edinburgh`)
- Registry lists this organization as a collaborator: National University of Ireland, Galway, Ireland (`cardio:org-national-university-of-ireland-galway-ireland`)
- Registry lists this organization as a collaborator: Universitaire Ziekenhuizen KU Leuven (`cardio:org-universitaire-ziekenhuizen-ku-leuven`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial (`cardio:pubmed-38857611`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial (`cardio:pubmed-42032972`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial (`cardio:pubmed-42418305`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of colchicine for secondary prevention according to stroke subtype: A secondary analysis of the CONVINCE randomized trial (`cardio:pubmed-41328787`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis (`cardio:pubmed-42619594`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4f3b6a111ad62d89057fd2322c3688751c95c92187cc649efe45a1243c19ee12
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
